Elyse Reed is a pharmacist who is specialized in Geriatric in Phoenix, Arizona. Patients can reach her at 1001 E Acoma Dr, Phoenix or contact her on 602-993-7359. Active license number of Elyse Reed is 5157 for Geriatric in Arizona. Elyse Reed is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Elyse Reed speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Elyse Reed
Specialization:
Geriatric
Credentials:
B.S. PHARMACY
Gender:
Female
Location:
1001 E Acoma Dr, Phoenix, Arizona, 85022-4323
Phone:
602-993-7359
Fax:
480-314-6821
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Elyse Reed are as mentioned below.
NPI Number:
1689884363
NPI Enumeration Date:
23 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elyse Reed are as mentioned below.
Specialization
License Number
State
Status
Geriatric
5157
Arizona
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1001 E Acoma Dr, Phoenix, Arizona
Zip:
85022-4323
Phone Number:
602-993-7359
Fax Number:
480-314-6821
Patients can reach Elyse Reed at 1001 E Acoma Dr, Phoenix, Arizona or can call on phone at 602-993-7359.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.